جستجوی استاد راهنمای دانشگاهی

Vincent Quagliarello, MD, is Professor of Medicine in the Department of Infectious Diseases at Yale School of Medicine, where he also serves as Clinical Chief of Infectious Diseases and Vice Chair for Education and Academic Affairs in the Department of Internal Medicine. His research focuses on infections among older adults, with particular expertise in endocarditis, meningitis, and antimicrobial stewardship in geriatric populations. Dr. Quagliarello has been an NIH R01-funded principal investigator studying infections in older adults and received an NIH K07 Academic Leadership Award to mentor postdoctoral trainees and junior faculty. His publication record demonstrates consistent focus on antimicrobial use in elderly patients, particularly those with advanced cancer, nursing home residents, and end-of-life care scenarios. His research has significantly contributed to understanding appropriate antimicrobial therapy in geriatric populations and the management of infections in complex elderly patients. Scientific Awards: Clinical Teacher Award (2011) from Infectious Diseases Society of America Leah Lowenstein Award (2007) from Yale School of Medicine Department of Internal Medicine Teacher of the Year (1998, 1990) Laureate Award (1997) from American College of Physicians (CT Chapter) Bohmfalk Teaching Prize (1997) from Yale School of Medicine Dr. Quagliarello has served as an educational leader at Yale, directing the Internal Medicine Clerkship, the Yale Infectious Diseases Fellowship program, and creating the Department of Medicine Research in Residency Program. His clinical work spans the spectrum of infectious diseases with a special focus on public health impact.

• Infectious Diseases
• Geriatric Infectious Diseases
• Antimicrobial Stewardship
• +۷ مورد دیگر

Dane Morgan is a Professor in the Department of Materials Science & Engineering at the University of Wisconsin-Madison, College of Engineering. His research focuses on computational materials science for materials design, including ab initio electronic structure modeling, multiscale methods, and machine learning applications in materials discovery. His work spans nuclear materials, battery and fuel cell electrodes, and electronic materials. Education : PhD, 1998, University of California, Berkeley MS, 1994, University of California, Berkeley BA, 1992, Swarthmore College Research Interests : Computational materials science, ab initio methods for electronic structure and thermokinetics, machine learning for materials discovery, electrochemical systems modeling, and applications in nuclear materials, batteries, and electronic materials. His work integrates advanced computational techniques with experimental validation. Scientific Awards : 2024 APL Materials, Editors Pick 2023 Microscopy and Microanalysis Best Paper Award (Instrumentation and Software category) 2023 IEEE Transactions on Plasma Science Best Paper Award 2023 Kellet Mid-Career Award 2015 TMS Materials Genome Initiative Ambassador 2006 3M Technical Nontenured Faculty Grant

• Computational materials science
• Ab initio electronic structure
• Multiscale methods
• +۴ مورد دیگر

Aida Maria de Oliveira Cruz Mendes is a distinguished academic and researcher at the Coimbra School of Nursing, where she has maintained a continuous appointment since 1987. With over three decades of academic service, she has established herself as a leading expert in nursing science with particular specialization in mental health, occupational health, and sleep quality among healthcare professionals. She currently serves on the Scientific Council for Life and Health Sciences at the Foundation for Science and Technology, demonstrating her significant contribution to Portuguese scientific policy. Education background: PhD from University of Minho (1996-2000) Master's in Occupational Health and Hygiene from University of Coimbra Medical School (1992-1995) License in Mental Health and Psychiatric Nursing (1990-1991) Bachelor's degree in Nursing (1977-1980) Multiple specialized certifications in psycho-oncology, cognitive therapy, and qualitative research Dr. Mendes' research program demonstrates remarkable consistency in addressing critical issues in nursing practice and healthcare delivery. Her work spans mental health services evaluation, occupational health challenges faced by nursing staff, sleep quality determinants in healthcare settings, and innovative programs for healthy aging and retirement transition. She has developed expertise in both qualitative and quantitative methodologies, with numerous systematic reviews and intervention studies to her credit. Her research bridges clinical practice with health promotion initiatives, creating tangible impacts on nursing education and healthcare policy. Analysis of her recent publication trajectory reveals a sophisticated evolution in research focus. While maintaining consistent attention to nursing staff wellbeing (particularly regarding sleep quality and stress biomarkers), she has expanded into developing and evaluating health promotion programs, most notably the REATIVA program for retirement transition. Her work increasingly incorporates international collaborations and demonstrates methodological sophistication, with publications appearing in multiple languages (Portuguese, English, and Spanish) across diverse healthcare contexts. Research funding highlights: Active Retirement: study of a healthy ageing promotor program (2013-2015) funded by Foundation for Science and Technology Mental Health Education and Sensibilization: A School-based Intervention Program for Adolescents and Young (2011-2014) funded by Foundation for Science and Technology Dr. Mendes has supervised numerous graduate students and collaborated extensively with international research teams, particularly in European nursing education contexts. Her work on nurse professional competence assessment among newly graduated nurses demonstrates her commitment to advancing nursing education standards. She maintains active research partnerships with institutions across Portugal and internationally, contributing to both clinical practice improvements and healthcare policy development.

• Nursing
• Mental Health
• Occupational Health
• +۴ مورد دیگر

Olivier Lortholary is Professor of Medicine at Paris Descartes University and holds multiple significant positions in the field of medical mycology and infectious diseases. He serves as Deputy Director of the French National Reference Center for Invasive Mycoses and Antifungals, and is Head of the Necker-Pasteur Center for Infectious Diseases and Tropical Medicine at Necker Hospital in Paris. His work is closely associated with the Institut Pasteur in Paris, France, where he is actively involved in research and teaching initiatives. Dr. Lortholary's educational background includes an M.D. from the Paris 6 School of Medicine and a Ph.D. from Paris 7 University. His extensive academic career has positioned him as a leading expert in medical mycology, with particular focus on fungal infections in immunocompromised patients. His research primarily centers on translational aspects of medical mycology, with special emphasis on Cryptococcus neoformans and cryptococcal meningitis, which represents the leading opportunistic fungal infection in advanced HIV-infected patients. He also investigates new immune deficiencies that predispose individuals to invasive fungal infections, develops diagnostic and therapeutic innovations for these conditions, and conducts clinical and microbiological studies of central nervous system infections and emerging infectious diseases. Dr. Lortholary has made substantial contributions to the field, with over 590 published papers, including more than 12 invited contributions to prestigious journals such as Clinical Infectious Diseases and Lancet Infectious Diseases. His research spans epidemiology of fungal infections, antifungal susceptibility testing, and clinical management approaches across various patient populations. He plays a significant role in shaping clinical guidelines as a member of various international expert panels, including the Infectious Diseases Society of America (for cryptococcosis management), the American Society of Transplantation (for donor-derived fungal infections), and ESCMID (for Candida and other fungal infections). Additionally, he serves as the French representative on the EUCAST Antifungal Susceptibility Testing Committee. As an educator, Dr. Lortholary co-directs the Medical Mycology course at the Pasteur Institute and has developed a MOOC (Massive Open Online Course) on Medical Mycology available through FUN-MOOC, reaching a global audience of healthcare professionals and researchers.

• Medical Mycology
• Infectious Diseases
• Translational Research
• +۷ مورد دیگر

Dr. Arpan Mehta is an Independent Investigator at the MRC Protein Phosphorylation and Ubiquitylation Unit, specializing in neurodegenerative diseases with a focus on Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia. He was awarded the 51st Sir John Halliday Croom Medal and Lectureship by the Royal College of Physicians of Edinburgh for his groundbreaking research on ALS mechanisms. His work explores the role of kinases and genetic mutations (e.g., C9ORF72) in neurodegeneration, alongside mitochondrial dysfunction and clinical trial methodologies. Research interests include molecular mechanisms underlying ALS, neuroimmunology, and improving clinical trial designs for neurodegenerative diseases. Dr. Mehta advocates for rigorous research standards, addressing reproducibility challenges, and optimizing therapeutic approaches. His recent studies investigate mitochondrial bioenergetic deficits in ALS motor neurons and the impact of cerebrospinal fluid (CSF) toxicity. Awards: Sir John Halliday Croom Medal and Lectureship (2025) His publications span clinical neurology, neurodegenerative disease mechanisms, and ethical aspects of medical practice. Dr. Mehta emphasizes interdisciplinary collaboration to advance understanding of ALS pathogenesis and translational therapies.

• Neurodegenerative Diseases
• Amyotrophic Lateral Sclerosis (ALS)
• Molecular Neuroscience
• +۳ مورد دیگر

Dr. Kiran T. Thakur serves as the Herbert Irving Associate Professor of Neurology at Columbia University Irving Medical Center and practices as an inpatient neurologist at NewYork-Presbyterian/CUIMC. Her clinical expertise spans neuroinfectious diseases, neuroimmunology, emergency neurology, and global health, with active clinical and research engagements across eight countries in Africa, Southeast Asia, and the Caribbean. She holds leadership roles including Neurology Clerkship Director at Perdana University Graduate School of Medicine (Malaysia) and serves as a neurology consultant for the World Health Organization. Her educational background includes an MD from Tufts University School of Medicine (2008), internship at Johns Hopkins Hospital's Osler Medical Service, neurology residency at Harvard's Brigham & Women's Hospital (where she served as chief resident), and fellowship in neuroinfectious disease/neuroimmunology at Johns Hopkins Hospital. She is additionally pursuing a Master of Science in clinical trials at the London School of Tropical Medicine and Hygiene. Dr. Thakur's research program focuses on improving detection and management of neuroinfectious diseases in hospital settings, with particular emphasis on vulnerable populations including HIV-positive individuals and immigrants. Her work integrates clinical, translational, and implementation science approaches to address cerebral malaria, tuberculous meningitis, Zika-related complications, and SARS-CoV-2 neurological outcomes. Current projects investigate novel diagnostics for infectious meningoencephalitis, risk factors for neuroinvasive infections, and therapeutic strategies for viral encephalitis. Analysis of her 15 most recent publications reveals consistent focus on neuroinfectious disease epidemiology (particularly in resource-limited settings), diagnostic challenges in immunocompromised patients, and global health implementation strategies. Her work prominently features Zika virus complications, tuberculous meningitis management, and CNS infections in travelers, reflecting her dual expertise in tropical medicine and neuroimmunology. Scientific recognition includes: Lewis P. Rowland Teaching Award (Columbia University, 2016) CDC Nakona Citation Award (2014) Dr. Thakur directs the NIH NINDS K23-funded study on pathogen identification in neurological infections (2018-2023) and leads Columbia's post-doctoral neuroinfectious disease fellowship for physician-scientists from low/middle-income countries. Her research program receives support from the NIH, World Federation of Neurology, and American Academy of Neurology, with implementation studies conducted in collaboration with WHO, PAHO, and CDC. The Thakur Laboratory at Columbia's Neurological Institute coordinates international research networks across Malawi, Vietnam, Bangladesh, Uganda, and the Dominican Republic. Her team conducts clinical trials on antimicrobial dosing, develops diagnostic algorithms for resource-limited settings, and implements training programs to build neuroinfectious disease capacity in underserved regions, with current emphasis on SARS-CoV-2 neurological sequelae and tropical disease management.

• Neuroinfectious Diseases
• Neuroimmunology
• Global Health
• +۶ مورد دیگر

Dr. David R Boulware is a Professor in the Department of Infectious Disease and International Medicine at the University of Minnesota Medical School. He is an infectious disease physician-scientist with formal training in public health, clinical trials, and tropical medicine. As a translational researcher, he combines clinical research training with basic science investigations into disease pathogenesis. His primary research interests include: Meningitis in resource-limited areas Diagnosis, prevention, and treatment of meningitis HIV-associated cryptococcal meningitis TB meningitis diagnostics Cryptococcal antigen screening Cost-effectiveness analyses in global health Dr. Boulware's research focuses on improving clinical outcomes of HIV-infected persons with meningitis, particularly cryptococcal meningitis which is the second most common AIDS-defining opportunistic infection in Sub-Saharan Africa and the most common cause of adult meningitis. His work has significant implications for global health, contributing to UN Sustainable Development Goals related to health and well-being. His recent publications (2025) demonstrate continued focus on cryptococcal meningitis treatment strategies, TB meningitis chemotherapy, and AIDS-related fungal infections. These works reflect his ongoing commitment to advancing treatment protocols for meningitis in both resource-limited and developed settings. Dr. Boulware has received substantial research funding, with 41 projects and grants totaling significant NIH support. His current active projects include: Midcareer Mentoring for Clinical Research in HIV/AIDS-related cryptococcal and TB meningitis (2024-2029) Improving outcomes in HIV-associated opportunistic infections using CNS pharmacokinetics and pharmacodynamics (2024-2029) Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium (2024-2029) He maintains active research collaborations in Uganda, South Africa, Tanzania, and Ethiopia, leading a multidisciplinary international research team. Dr. Boulware is currently accepting PhD students for projects related to meningitis epidemiology, prevention, diagnostics, treatment, and clinical trials.

• Infectious Diseases
• Meningitis Epidemiology
• HIV-Associated Opportunistic Infections
• +۵ مورد دیگر

Tihana Bicanic is Professor of Infectious Diseases and Mycology at St George's University of London, holding honorary appointments at the MRC Centre for Medical Mycology (University of Exeter) and serving as Director of the Infection Clinical Academic Group. Her clinical and translational research focuses on invasive fungal infections, particularly cryptococcal meningitis in HIV patients and ICU-acquired candidiasis/aspergillosis. She leads the CandiRes study on Candida resistance evolution and previously directed the AspiFlu project on influenza/COVID-associated aspergillosis. Key research domains: Cryptococcal meningitis pathogenesis and treatment optimization Antifungal resistance mechanisms and prevention strategies Genomic epidemiology of fungal pathogens Immunotherapy for fungal infections Her group's publications demonstrate consistent focus on clinical mycology, antimicrobial resistance, and immunopathology. Recent work emphasizes diagnostic innovation, therapeutic optimization, and translational approaches for critical care mycoses. Awards and recognition include: Fellowship in the European Confederation of Medical Mycology (FECMM) Member of Wellcome Trust's Pathogen Biology and Disease Transmission Discovery Advisory Group Research team includes laboratory technicians and clinical research fellows investigating fungal pathogenesis and treatment strategies across multiple UK ICUs.

• Invasive Fungal Infections
• Antifungal Resistance
• Cryptococcal Meningitis
• +۲ مورد دیگر

David R. Raleigh, MD, PhD, is an Assistant Professor in the Departments of Radiation Oncology and Neurological Surgery at the University of California San Francisco (UCSF). He serves as a Principal Investigator at the Brain Tumor Center and Director of the Preclinical Therapeutics Core. Education: BA in Molecular and Cell Biology and Cognitive Science (UC Berkeley, 2004), MD and PhD in Pathology (University of Chicago, 2012), Residency in Radiation Oncology (UCSF, 2017) His research focuses on the molecular mechanisms of brain tumor growth, particularly meningiomas, integrating developmental biology with oncology to identify novel treatments. Methodologies include biochemistry, mouse genetics, genomics, and pharmacology. Dr. Raleigh's recent publications highlight molecular classification of meningiomas, genomics, and targeted therapies. Awards include Phi Beta Kappa, multiple travel grants, and the Robert and Ruth Halperin Endowed Chair in Meningioma Research.

• Neuro-oncology
• Radiation Oncology
• Molecular Mechanisms of Brain Tumors
• +۳ مورد دیگر

Maria Björkqvist is a Professor at Lund University, affiliated with the Biomarkers in Brain Disease research team and serving as Dean of the Faculty of Medicine . She is a Principal Investigator at MultiPark , a multidisciplinary initiative focused on Parkinson’s disease. Her research bridges neurodegenerative disease pathology and therapeutic development. Research Interests : Maria investigates peripheral disease manifestations in Huntington’s disease, exploring how these mirror neuronal pathology to identify biomarkers and therapeutic avenues. Her work extends to Alzheimer’s disease (via neurovascular coupling studies) and Parkinson’s disease collaborations. Publications : Her recent articles focus on glucose transporter dysfunction, adipocyte size alterations, hypothalamic-striatal neuropathology, inflammation biomarkers, and blood-brain barrier preservation in Alzheimer’s models. These studies highlight metabolic, neuroinflammatory, and gender-specific subfields. Supervision & Grants : She served on the examining committee for PhD student Liana Fasching. She leads projects like Exploring the Role of Meningeal Immune Alteration in Huntington’s Disease (Ulm University Hospital, 2024–2025) and contributed to the long-term BAGADILICO initiative for basal ganglia disorders. Labs & Collaborations : Maria collaborates within Lund University’s Faculty of Medicine and MultiPark , integrating multidisciplinary approaches to neurodegenerative disease research.

• Huntington's Disease
• Neurodegenerative Disorders
• Biomarkers in Brain Diseases
• +۱۰ مورد دیگر

Dr. XiuJun Li is a Professor in the Department of Chemistry and Biochemistry at The University of Texas at El Paso (UTEP) within the College of Science. He leads the Li Microfluidic Lab-on-a-Chip & Nanotechnology Group, focusing on the development of cutting-edge, low-cost diagnostic technologies for applications in bioanalysis, biomedical engineering, forensic science, and environmental science. His work is highly interdisciplinary, bridging chemistry, engineering, and biology. Dr. Li's primary research interests lie in microfluidics, nanotechnology, lab-on-a-chip systems, and point-of-care diagnostics. His lab specializes in creating paper and polymer hybrid microfluidic devices for the ultrasensitive detection of cancer biomarkers, infectious diseases (such as SARS-CoV-2 and pertussis), and environmental toxins. A significant focus is on making these devices instrument-free and affordable, particularly for use in resource-limited settings and rural areas. His recent work on a $3 paper-based cancer detector has garnered significant media attention, including features in the New York Post and local TV stations. The trend in Dr. Li's recent publications reveals a strong emphasis on developing portable, visual, and quantitative diagnostic platforms. His research frequently involves the integration of nanomaterials for signal amplification, the use of microfluidic chips for controlled reactions, and innovative readout methods like bar-chart displays and smartphone-based detection, all aimed at creating practical tools for real-world healthcare challenges. Dr. Li has received substantial recognition for his contributions to science, including being named one of the World's Top 2% of Cited Researchers by Elsevier and a Top Scholar by ScholarGPS. He is an Editorial Board Member for Microsystems & Nanoengineering (Nature Publishing Group) and has been awarded a Travel Grant from GEM on the Road’s PFI Programming. He holds patents for his inventions in biosensing and photothermal detection. Dr. Li is a dedicated mentor and educator. He has advised numerous PhD and Master's students, many of whom have gone on to prestigious postdoctoral positions at institutions like Harvard, UPenn, and MD Anderson. He is also the Director of the Forensic Science program at UTEP, where he organizes outreach events to engage students. His lab is actively involved in research, with multiple postdoctoral fellows and graduate students currently working on projects related to cancer detection and infectious disease study.

• Microfluidics
• Nanotechnology
• Lab-on-a-Chip
• +۹ مورد دیگر

Dr. Shabir A. Madhi is a pioneering Professor of Vaccinology at the University of the Witwatersrand and Executive Director of the Vaccines and Infectious Diseases Analytics (VIDA) Research Unit . His work spans infectious diseases, public health, and vaccine development , with a focus on vulnerable populations in low- and middle-income countries. His research explores vaccine immunogenicity and safety , including pneumococcal and COVID-19 vaccines, while advancing diagnostic technologies like high-throughput PCR for bacterial detection. Publications appear in Nature Immunology , The Lancet , and Vaccine , reflecting his influence in global health. Dr. Madhi collaborates with institutions such as the South African Medical Research Council , University of Pretoria , and King Saud University , supported by grants from the Bill & Melinda Gates Foundation , NIH , and CDC . His studies on respiratory infections and HIV interactions shape public health policies across Africa.

• Vaccinology
• Infectious Diseases
• Public Health
• +۶ مورد دیگر

Bjoern Menze is a Professor and Rudolf Mößbauer Tenure Track Chair at the Technical University of Munich (TUM), leading the Image-based Biomedical Modeling Group within the Munich School of Bioengineering. His research focuses on medical image computing, tumor growth modeling, and computational physiology, with applications in clinical neuroimaging and personalized radiotherapy design. He holds a Ph.D. in Computer Science from Heidelberg University and has held positions at ETH Zurich, INRIA Sophia Antipolis, MIT, and Harvard Medical School. His academic journey includes a postdoc at MIT’s CSAIL and Harvard Medical School, followed by roles at ETH Zurich and INRIA. His work bridges biomedical imaging with machine learning, emphasizing model-driven analysis of physiological processes. He has been a visiting professor at Maastricht University and contributes to initiatives like the Center for Translational Cancer Research at TUM. Key research areas include tumor growth modeling, quantitative imaging biomarkers, and integrating mathematical models with clinical data. His awards include the MICCAI Young Scientist Award (2014), Leopoldina Fellowship (2009), and DFG Research Fellowship (2008). He advises on medical AI, leads interdisciplinary projects, and publishes extensively in top journals like Nature Neuroscience and IEEE Transactions on Medical Imaging. His lab’s work spans applications such as glioblastoma radiotherapy optimization, whole-body bone lesion detection, and neural connectivity imaging. Collaborations include institutions like Harvard, MIT, and ETH Zurich. He emphasizes translating computational methods into clinical practice for personalized healthcare solutions.

• Medical Image Computing
• Tumor Growth Modeling
• Computational Physiology
• +۳ مورد دیگر

Adam de Havenon, MD, MSCI is an Associate Professor of Neurology at Yale School of Medicine specializing in vascular neurology. He leads the de Havenon Lab which focuses on reducing stroke risk, preventing recurrent strokes, and improving post-stroke recovery outcomes. His clinical practice includes evaluating and treating acute strokes in hospital and emergency settings, as well as providing outpatient stroke consultations. Dr. de Havenon earned his BA in American Studies from Yale University in 2001, followed by his MD from Brown Medical School in 2009. He completed neurology residency at the University of Utah in 2013 and a vascular neurology fellowship at University of Washington in 2014. In 2021, he completed a Masters of Science in Clinical Investigation degree. After serving as faculty at the University of Utah from 2014-2021, he returned to Yale in late 2021. His research spans intracranial atherosclerosis, blood pressure variability, vascular cognitive impairment, white matter hyperintensity, and advanced neuroimaging techniques. Dr. de Havenon has published over 150 peer-reviewed articles and his work focuses on bridging basic science of stroke research with human implementation. His publications from 2024-2025 demonstrate strong emphasis on stroke risk prediction, vascular risk factor management, neuroimaging techniques, and health disparities in stroke outcomes. Dr. de Havenon has secured competitive grant funding including K23, R01, and UG3/UH3 awards from NIH/NINDS. He serves as principal investigator for the BP-VISO study and StrokeNet study CAPTIVA-MRI. His mentees have received prestigious awards including NIH NRS training grants and American Academy of Neurology Medical Student Research Scholarships. He established the de Havenon Lab first at his prior institution and then at Yale in 2022, where it continues to expand its footprint in cerebrovascular research and training the next generation of researchers. The lab's mission is to advance research that benefits stroke patients while addressing gaps and disparities in stroke prevention and care.

• Stroke
• Vascular Neurology
• Intracranial Atherosclerosis
• +۵ مورد دیگر

Markus Hovd is a Senior Lecturer at the Section for Pharmacology and Pharmaceutical Biosciences within the Department of Pharmacy at the University of Oslo's Faculty of Mathematics and Natural Sciences. He also maintains an affiliation with the Neurosurgical Department. His work focuses on pharmacokinetic research with applications in clinical practice and personalized medicine. Philosophiae Doctor (PhD), Department of Pharmacy, University of Oslo, 2024 Master of Pharmacy, Department of Pharmacy, University of Oslo, 2019 Hovd's primary research interest centers on the mechanisms behind pharmacokinetic inter-individual variability and the development of models to aid in personalization of medicine. His research methodology includes population- and physiology-based pharmacokinetic models, in vitro-in vivo extrapolation, and clinical trials. His work spans multiple therapeutic areas including kidney transplantation, obesity-related pharmacokinetics, and cerebrospinal fluid dynamics. Analysis of Hovd's publications reveals a strong focus on pharmacokinetic applications in specialized patient populations, particularly kidney transplant recipients and patients who have undergone bariatric surgery. His research demonstrates expertise in population pharmacokinetic modeling, drug transport mechanisms, and the impact of physiological changes on drug disposition. A significant portion of his work addresses the challenges of drug dosing in complex clinical scenarios where standard pharmacokinetic assumptions may not apply. Hovd serves as a representative for temporary teaching staff on both the Teaching Committee and the Department Board at the Department of Pharmacy. His teaching portfolio includes courses in Pharmaceutical Biochemistry, Pharmacotherapy, Pharmaceutical Microbiology, Research Preparation in Biology, and Applied Pharmacokinetics and Dosing in Clinical Practice. Hovd is actively involved in multiple research groups including Pharmacokinetics, Kidney Transplant Medicine, and the KG Jebsen Center for Cerebrospinal Fluid Research, where he contributes his pharmacokinetic expertise to interdisciplinary neuroscience research.

• Pharmacokinetics
• Pharmacometrics
• Population pharmacokinetics
• +۵ مورد دیگر